Intervene with Jakafi

Explore the data through expert perspectives

POLYCYTHEMIA VERA (PV)

For treatment of PV in adults who have had an inadequate response to or are intolerant of hydroxyurea

Claire Harrison, DM, FRCPath

MPN Expert

Dr Claire Harrison
MYELOFIBROSIS (MF)

For treatment of intermediate- or high-risk MF, including primary MF, post–polycythemia vera MF, and post–essential thrombocythemia MF in adults

Ruben Mesa, MD, FACP

MPN Expert

Dr Mesa
CHRONIC GRAFT-VERSUS- HOST DISEASE (cGVHD)

For treatment of cGVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older

Preet M. Chaudhary, MD, PhD

GVHD Expert

Dr Chaudhary
ACUTE GRAFT-VERSUS-HOST DISEASE (aGVHD)

For treatment of steroid-refractory aGVHD in adult and pediatric patients 12 years and older

Pashna Munshi, MD

GVHD Expert

Dr Munshi
Dr Claire Harrison

POLYCYTHEMIA VERA (PV)

For treatment of PV in adults who have had...

Claire Harrison, DM, FRCPath

MPN Expert

Dr Mesa

MYELOFIBROSIS (MF)

For treatment of intermediate- or high-risk...

Ruben Mesa, MD, FACP

MPN Expert

Dr Chaudhary

CHRONIC GRAFT-VERSUS- HOST DISEASE (cGVHD)

For treatment of cGVHD after failure of one...

Preet M. Chaudhary, MD, PhD

GVHD Expert

Dr Munshi

ACUTE GRAFT-VERSUS-HOST DISEASE (aGVHD)

For treatment of steroid- refractory aGVHD i...

Pashna Munshi, MD

GVHD Expert